Synergistic anticancer therapeutic effect of sorafenib and microRNA-21 inhibitor in Hepatocellular carcinoma

被引：0
|
作者：
Kim, J. Y. [1 ,2 ]
Lee, J. Y. [1 ,2 ]
Lee, R. J. [1 ]
Kim, M. H. [1 ,2 ]
Hwang, S. H. [1 ]
Song, G. W. [1 ]
Lee, S. G. [1 ]
Tak, E. Y. [1 ]
机构：
[1] Asan Med Ctr, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Ulsan, South Korea
来源：
HUMAN GENE THERAPY | 2019年 / 30卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P142
引用
收藏
页码：A61 / A61
页数：1
相关论文
共 50 条
  • [41] Interaction of microRNA-21/145 and Smad3 domain-specific phosphorylation in hepatocellular carcinoma
    Wang, Ji Yu
    Fang, Meng
    Boye, Alex
    Wu, Chao
    Wu, Jia Jun
    Ma, Ying
    Hou, Shu
    Kan, Yue
    Yang, Yan
    ONCOTARGET, 2017, 8 (49): : 84958 - 84973
  • [42] MicroRNA-21: a therapeutic target for reversing drug resistance in cancer
    Hong, Liu
    Han, Yu
    Zhang, Yujie
    Zhang, Hongwei
    Zhao, Qingchuan
    Wu, Kaichun
    Fan, Daiming
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2013, 17 (09) : 1073 - 1080
  • [43] Overexpression of microRNA-21 strengthens stem cell-like characteristics in a hepatocellular carcinoma cell line
    Jiang, Jinghang
    Yang, Peipei
    Guo, Zhe
    Yang, Rirong
    Yang, Haojie
    Yang, Fuquan
    Li, Lequn
    Xiang, Bangde
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2016, 14
  • [44] MicroRNA-21 Silencing in Diabetic Nephropathy: Insights on Therapeutic Strategies
    Dhas, Yogita
    Arshad, Numair
    Biswas, Nupur
    Jones, Lawrence D.
    Ashili, Shashaanka
    BIOMEDICINES, 2023, 11 (09)
  • [45] MicroRNA-21 as a novel therapeutic target for COVID-19
    Beck, C.
    Ramanujam, D. P.
    Vaccarello, P.
    Widenmeyer, F.
    Feuerherd, M.
    Schaedler, J.
    Sperhake, J. P.
    Pueschel, K.
    Graw, M.
    Safi, S.
    Hoffmann, H.
    Protzer, U.
    Engelhardt, S.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2022, 395 (SUPPL 1) : S60 - S60
  • [46] Circulating MicroRNA-21 as a Novel Noninvasive Biomarker for Hepatocellular Carcinoma Compared with Alpha Fetoprotein Gold Test
    Osman, Asmaa Gamal
    Hashem, Khalid Shaaban
    Youssef, Laila Mohamed
    Nabil, Ahmed
    JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2021, 15 (04): : 2473 - 2485
  • [47] Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma
    Shimizu, Satoshi
    Takehara, Tetsuo
    Hikita, Hayato
    Kodama, Takahiro
    Tsunematsu, Hinako
    Miyagi, Takuya
    Hosui, Atsushi
    Ishida, Hisashi
    Tatsumi, Tomohide
    Kanto, Tatsuya
    Hiramatsu, Naoki
    Fujita, Naonobu
    Yoshimori, Tamotsu
    Hayashi, Norio
    INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (03) : 548 - 557
  • [48] Synergistic antitumor effect of AUY922 in combination with sorafenib in hepatocellular carcinoma cells
    Lau, Chi-Keung
    Yang, Z. F.
    Ho, D. W.
    Lam, C. T.
    Pang, R.
    Fan, S. T.
    Poon, R. T.
    CANCER RESEARCH, 2011, 71
  • [49] SYNERGISTIC ANTI-TUMOR EFFECT OF SORAFENIB IN COMBINATION WITH AKT INHIBITORS IN HEPATOCELLULAR CARCINOMA
    Feng, W. -C.
    Hsu, C. -H.
    Lin, S. -D.
    Lin, H. -H.
    Hsu, D. -W.
    Huang, C. -C.
    Chow, L. -P.
    Cheng, A. -L.
    ANNALS OF ONCOLOGY, 2012, 23 : 16 - 16
  • [50] Lower Serum Sodium Levels Are Associated with the Therapeutic Effect of Sorafenib on Hepatocellular Carcinoma
    Tadashi Kegasawa
    Ryotaro Sakamori
    Kazuki Maesaka
    Ryoko Yamada
    Yuki Tahata
    Ayako Urabe
    Takahiro Kodama
    Hayato Hikita
    Kazuho Imanaka
    Kazuyoshi Ohkawa
    Naoki Hiramatsu
    Masahide Oshita
    Yukinori Yamada
    Masami Inada
    Takayuki Yakushijin
    Yasuharu Imai
    Tomohide Tatsumi
    Tetsuo Takehara
    Digestive Diseases and Sciences, 2021, 66 : 1720 - 1729
12345